blinatumomab
amgen
['blinatumomab']
blinatumomab improves survival in distinct subset of young, low-risk patients with b-all in first relapse #asco23 
Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition